Close

MYnd Analytics (MYND) Says FDA Designated Breakthrough Device Status for its PEER 4.0

September 17, 2018 8:44 AM EDT Send to a Friend
MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login